← Back
Data updated: Mar 10, 2026
SOLA PHARMS
Neurology
SOLA PHARMS is a generic drug manufacturer focused on Neurology.
2020
Since
4
Drugs
-
Trials
54
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TERIFLUNOMIDE 2025-08-06
Labeling
TERIFLUNOMIDE 2025-04-07
TERIFLUNOMIDE 2025-03-26
Labeling
TERIFLUNOMIDE 2025-03-26
Labeling
TERIFLUNOMIDE 2025-03-13
Labeling
TERIFLUNOMIDE 2025-03-13
Labeling
TERIFLUNOMIDE 2025-03-07
Labeling
TERIFLUNOMIDE 2025-03-07
Labeling
TERIFLUNOMIDE 2025-02-11
Labeling
CYANOCOBALAMIN 2025-02-07
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2020-06-17
- Latest
- 2025-03-07
- Applications
- 4